Digital CBT-I for Insomnia Disorder
CrEDIT
Clinical Effectiveness of Digital CBT-I for the Treatment of Insomnia Disorder: A Randomized Controlled Trial
1 other identifier
interventional
336
1 country
1
Brief Summary
This study will examine the effectiveness of digital CBT-I versus sleep hygiene education in reducing insomnia severity, sleep onset latency, and wake after sleep onset in those with insomnia disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 7, 2022
CompletedFirst Posted
Study publicly available on registry
September 15, 2022
CompletedStudy Start
First participant enrolled
November 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 24, 2023
CompletedApril 15, 2024
April 1, 2024
6 months
September 7, 2022
April 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in the Insomnia Severity Index (ISI)
Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity
From baseline to 10 weeks post-randomization
Change in sleep onset latency (SOL)
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
From baseline to 10 weeks post-randomization
Change in wake after sleep onset (WASO)
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
From baseline to 10 weeks post-randomization
Secondary Outcomes (9)
Insomnia Disorder remission (score <8) and response (change ≥6) on the ISI
10, 16, and 24 weeks post-randomization
Insomnia disorder remission based on the SCID Insomnia Module
Week -1 compared to weeks 10, 16, and 24 post-randomization
Change in sleep diary parameters: percent sleep efficiency (SE), total sleep time (TST), total time in bed (TTIB), and total wake time (TWT)
From lead-in period to 10, 16, and 24 weeks post-randomization
Change in the Sleep Condition Indicator (SCI-8)
From baseline to weeks 10, 16, and 24 post-randomization
Change in the Generalized Anxiety Disorder Questionnaire (GAD-7)
From baseline to weeks 10, 16, and 24 post-randomization
- +4 more secondary outcomes
Study Arms (2)
Digital CBT-I
EXPERIMENTALDigitally-delivered CBT for insomnia accessed via web and/or mobile app
Sleep hygiene education
ACTIVE COMPARATORThis group will receive access to sleep hygiene education delivered via digital written materials
Interventions
A fully-automated and personalized digital intervention based on principles from cognitive behavioral therapy for insomnia.
Participants will be provided with sleep hygiene advice which will be delivered digitally all at once upon allocation to the SHE arm. Participants will be able to revisit content during the trial as they wish.
Eligibility Criteria
You may qualify if:
- Age ≥22 years old
- Insomnia Disorder diagnosis
- Score ≤16 on the 8-item Sleep Condition Indicator
- \> 30 minutes sleep onset latency (SOL); and/or \> 30 minutes wake after sleep onset (WASO)
- Current resident of the USA
- Oral and written fluency in English
- Participant is able and willing to comply with protocol requirements, has been informed of the nature of the study, and has signed the IRB-approved informed consent form
You may not qualify if:
- Must not be currently receiving or be expecting to start CBT for insomnia during study participation, or have previously received CBT for insomnia in the past 12-months (self-report)
- If on psychoactive medication, including sleep medication, this must be stable for at least 5 half lives
- Past or present psychosis, schizophrenia, bipolar disorder, assessed by self-report and/or seizure disorder
- Occupation that requires alertness / caution to avoid accidents, for example long-haul driving, long distance bus driver, heavy machinery operator, air traffic controller
- Hearing or vision impairment that prevents effective use of the audio-visual content of digital CBT-I or SHE in the opinion of the investigator
- Intellectual disability or any Neurocognitive or Neurodevelopmental disorder that would prevent participants from following study procedures
- Any condition that the investigator believes would make participation in the study not in the best interest of the participant or would preclude successful completion of study activities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Big Health Inc.lead
- University of California, San Franciscocollaborator
Study Sites (1)
University of California, San Francisco
San Francisco, California, 94143, United States
Related Publications (1)
Prather AA, Krystal AD, Emsley R, Carl J, Ball T, Tarnai K, Aguilera A, Espie CA, Henry AL. The Effectiveness of Digital Cognitive Behavioral Therapy to Treat Insomnia Disorder in US Adults: Nationwide Decentralized Randomized Controlled Trial. JMIR Ment Health. 2025 Dec 4;12:e84323. doi: 10.2196/84323.
PMID: 41343796DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 7, 2022
First Posted
September 15, 2022
Study Start
November 8, 2022
Primary Completion
May 15, 2023
Study Completion
August 24, 2023
Last Updated
April 15, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share